amoxicillin-potassium-clavulanate-combination has been researched along with Liver-Failure--Acute* in 5 studies
1 review(s) available for amoxicillin-potassium-clavulanate-combination and Liver-Failure--Acute
Article | Year |
---|---|
Acute liver failure due to amoxicillin and amoxicillin/clavulanate.
The aim of our study is to report upon the presentation of two patients with life-threatening acute liver failure (ALF) due to amoxicillin and amoxicillin/clavulanate. A 59-year-old, Caucasian male presented with ALF 34 days after receiving amoxicillin/clavulanate. Despite aggressive supportive care, he died on hospital day 10. A 42-year-old, Caucasian female presented with ALF 21 days after receiving amoxicillin. She underwent successful liver transplantation on hospital day 19. In both cases, all competing causes of ALF had been excluded, liver pathology was consistent with drug-induced hepatitis, and cases were deemed "definite/highly probable" using causality assessment. Amongst 14 prior ALF/death cases due to amoxicillin/clavulanate, the mean age (62 years), male predominance (57%), and mean delay from drug cessation to presentation (17 days) is similar to what has been reported in patients with self-limited cholestatic hepatitis. Acute liver failure is a rare manifestation of amoxicillin and amoxicillin/clavulanate hepatotoxicity with no obvious clinical features at presentation portending a poor prognosis. Early transfer of patients with severe drug-induced hepatotoxicity (i.e., encephalopathy or coagulopathy) to a transplant center is recommended due to their poor likelihood of recovery. Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Fatal Outcome; Female; Humans; Liver Failure, Acute; Liver Transplantation; Male; Middle Aged | 2005 |
4 other study(ies) available for amoxicillin-potassium-clavulanate-combination and Liver-Failure--Acute
Article | Year |
---|---|
Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Drug-induced liver injury (DILI) is a frequent cause of liver injury and acute liver failure. We aimed to review all hospitalized DILI cases in a tertiary Egyptian center from January 2015 through January 2016. Cases with elevated alanine aminotransferase more than 3-fold and/or alkaline phosphatase more than 2-fold the upper limit of normal value were prospectively recruited and followed for one year. Drug history, liver biopsy whenever feasible and application of Roussel Uclaf Causality Assessment Method (RUCAM) were the diagnostic prerequisites after exclusion of other etiologies of acute liver injury. In order of frequency, the incriminated drugs were: Diclofenac (31 cases, 41.3%), amoxicillin-clavulanate (14 cases, 18.7%), halothane toxicity (8 cases, 10.7%), ibuprofen (4 cases, 5.3%), Khat (3 cases, 4%), tramadol (3 cases, 4%), Sofosbuvir with ribavirin (2 cases, 2.7%), and acetylsalicylic acid (2 cases, 2.7%) with one offending drug in 93.3% of cases. Forty-four cases (58.7%) were males; while 56 cases (74.7%) had HCV related chronic liver disease. Thirty-two cases (42.7%) presented with pattern of hepatocellular injury, while 23 cases (30.7%) were with cholestasis, and 20 cases (20.7%) with a mixed hepatocellular/cholestatic injury. One case received a transplant (0.75%), 7 cases died (9.3%), 23 cases (30.6%) developed liver decompensation (hepatic encephalopathy and ascites), and 44 cases completely resolved (58.7%). In conclusion, Diclofenac is the commonest offender in DILI occurrence in an Egyptian cohort. Age and prothrombin concentration were the only predictors of unfavorable outcomes of DILI. Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Cyclooxygenase Inhibitors; Diclofenac; Egypt; Female; Hepatic Encephalopathy; Humans; Liver; Liver Failure, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Tertiary Care Centers | 2020 |
Drug induced liver injury and its relationship to autoimmune hepatitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Anticholesteremic Agents; Autoantibodies; Chemical and Drug Induced Liver Injury; Diagnostic Techniques, Digestive System; Female; Genes, MHC Class II; Hepatitis, Autoimmune; Humans; Immunoglobulins; Jaundice; Liver; Liver Failure, Acute; Male; Registries | 2011 |
[Acute liver failure due to a treatment by nimesulide].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Halothane; Humans; Jaundice, Obstructive; Liver Failure, Acute; Liver Transplantation; Postoperative Complications; Sulfonamides; Time Factors | 2009 |
[Hepatic failure secondary to hepatitis due to amoxicillin-clavulanic acid. Treatment with corticoids].
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Drug Therapy, Combination; Glucocorticoids; Humans; Liver Failure, Acute; Male; Prednisone; Treatment Outcome | 2002 |